img

Global Influenza Drugs and Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Influenza Drugs and Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Influenza Drugs and Vaccines market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza Drugs and Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Viatris
Hulan Bio
Changchun Institute of Biological
Jiangsu GDK
Sinovac
Beike Bio
Segment by Type
Influenza Drugs
Influenza Vaccines

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Influenza Drugs and Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Influenza Drugs and Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Influenza Drugs and Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Influenza Drugs and Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Influenza Drugs and Vaccines introduction, etc. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Influenza Drugs and Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Influenza Drugs and Vaccines Market Overview
1.1 Influenza Drugs and Vaccines Product Overview
1.2 Influenza Drugs and Vaccines Market Segment by Type
1.2.1 Influenza Drugs
1.2.2 Influenza Vaccines
1.3 Global Influenza Drugs and Vaccines Market Size by Type
1.3.1 Global Influenza Drugs and Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Influenza Drugs and Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2024)
2 Global Influenza Drugs and Vaccines Market Competition by Company
2.1 Global Top Players by Influenza Drugs and Vaccines Sales (2018-2024)
2.2 Global Top Players by Influenza Drugs and Vaccines Revenue (2018-2024)
2.3 Global Top Players by Influenza Drugs and Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Influenza Drugs and Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Drugs and Vaccines Market Competitive Situation and Trends
2.5.1 Influenza Drugs and Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Drugs and Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Drugs and Vaccines Market
2.8 Key Manufacturers Influenza Drugs and Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Drugs and Vaccines Status and Outlook by Region
3.1 Global Influenza Drugs and Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Influenza Drugs and Vaccines Historic Market Size by Region
3.2.1 Global Influenza Drugs and Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Influenza Drugs and Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Influenza Drugs and Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Region
3.3.1 Global Influenza Drugs and Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Influenza Drugs and Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Influenza Drugs and Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Influenza Drugs and Vaccines by Application
4.1 Influenza Drugs and Vaccines Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Influenza Drugs and Vaccines Market Size by Application
4.2.1 Global Influenza Drugs and Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Influenza Drugs and Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2024)
5 North America Influenza Drugs and Vaccines by Country
5.1 North America Influenza Drugs and Vaccines Historic Market Size by Country
5.1.1 North America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Influenza Drugs and Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Influenza Drugs and Vaccines Sales in Value by Country (2018-2024)
5.2 North America Influenza Drugs and Vaccines Forecasted Market Size by Country
5.2.1 North America Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
6 Europe Influenza Drugs and Vaccines by Country
6.1 Europe Influenza Drugs and Vaccines Historic Market Size by Country
6.1.1 Europe Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Influenza Drugs and Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Influenza Drugs and Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Influenza Drugs and Vaccines Forecasted Market Size by Country
6.2.1 Europe Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Influenza Drugs and Vaccines by Region
7.1 Asia-Pacific Influenza Drugs and Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Influenza Drugs and Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Influenza Drugs and Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Influenza Drugs and Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Drugs and Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Influenza Drugs and Vaccines Sales in Value by Region (2024-2029)
8 Latin America Influenza Drugs and Vaccines by Country
8.1 Latin America Influenza Drugs and Vaccines Historic Market Size by Country
8.1.1 Latin America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Influenza Drugs and Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Influenza Drugs and Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Influenza Drugs and Vaccines Forecasted Market Size by Country
8.2.1 Latin America Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Influenza Drugs and Vaccines by Country
9.1 Middle East and Africa Influenza Drugs and Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Influenza Drugs and Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Influenza Drugs and Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Influenza Drugs and Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL
10.1.1 CSL Company Information
10.1.2 CSL Introduction and Business Overview
10.1.3 CSL Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CSL Influenza Drugs and Vaccines Products Offered
10.1.5 CSL Recent Development
10.2 Bristol Myers Squibb
10.2.1 Bristol Myers Squibb Company Information
10.2.2 Bristol Myers Squibb Introduction and Business Overview
10.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Products Offered
10.2.5 Bristol Myers Squibb Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 AstraZeneca Influenza Drugs and Vaccines Products Offered
10.3.5 AstraZeneca Recent Development
10.4 Eli Lilly
10.4.1 Eli Lilly Company Information
10.4.2 Eli Lilly Introduction and Business Overview
10.4.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eli Lilly Influenza Drugs and Vaccines Products Offered
10.4.5 Eli Lilly Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Roche Influenza Drugs and Vaccines Products Offered
10.5.5 Roche Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Novartis
10.7.1 Novartis Company Information
10.7.2 Novartis Introduction and Business Overview
10.7.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novartis Influenza Drugs and Vaccines Products Offered
10.7.5 Novartis Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Pfizer Influenza Drugs and Vaccines Products Offered
10.8.5 Pfizer Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sanofi Influenza Drugs and Vaccines Products Offered
10.9.5 Sanofi Recent Development
10.10 Bayer
10.10.1 Bayer Company Information
10.10.2 Bayer Introduction and Business Overview
10.10.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bayer Influenza Drugs and Vaccines Products Offered
10.10.5 Bayer Recent Development
10.11 Celgene
10.11.1 Celgene Company Information
10.11.2 Celgene Introduction and Business Overview
10.11.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Celgene Influenza Drugs and Vaccines Products Offered
10.11.5 Celgene Recent Development
10.12 Seqirus
10.12.1 Seqirus Company Information
10.12.2 Seqirus Introduction and Business Overview
10.12.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Seqirus Influenza Drugs and Vaccines Products Offered
10.12.5 Seqirus Recent Development
10.13 Protein Sciences Corporation
10.13.1 Protein Sciences Corporation Company Information
10.13.2 Protein Sciences Corporation Introduction and Business Overview
10.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Products Offered
10.13.5 Protein Sciences Corporation Recent Development
10.14 Serum Institute of India
10.14.1 Serum Institute of India Company Information
10.14.2 Serum Institute of India Introduction and Business Overview
10.14.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Serum Institute of India Influenza Drugs and Vaccines Products Offered
10.14.5 Serum Institute of India Recent Development
10.15 Emergent Biosolutions
10.15.1 Emergent Biosolutions Company Information
10.15.2 Emergent Biosolutions Introduction and Business Overview
10.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
10.15.5 Emergent Biosolutions Recent Development
10.16 BioCryst Pharmaceuticals
10.16.1 BioCryst Pharmaceuticals Company Information
10.16.2 BioCryst Pharmaceuticals Introduction and Business Overview
10.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Products Offered
10.16.5 BioCryst Pharmaceuticals Recent Development
10.17 Alvogen
10.17.1 Alvogen Company Information
10.17.2 Alvogen Introduction and Business Overview
10.17.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Alvogen Influenza Drugs and Vaccines Products Offered
10.17.5 Alvogen Recent Development
10.18 Viatris
10.18.1 Viatris Company Information
10.18.2 Viatris Introduction and Business Overview
10.18.3 Viatris Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Viatris Influenza Drugs and Vaccines Products Offered
10.18.5 Viatris Recent Development
10.19 Hulan Bio
10.19.1 Hulan Bio Company Information
10.19.2 Hulan Bio Introduction and Business Overview
10.19.3 Hulan Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Hulan Bio Influenza Drugs and Vaccines Products Offered
10.19.5 Hulan Bio Recent Development
10.20 Changchun Institute of Biological
10.20.1 Changchun Institute of Biological Company Information
10.20.2 Changchun Institute of Biological Introduction and Business Overview
10.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Products Offered
10.20.5 Changchun Institute of Biological Recent Development
10.21 Jiangsu GDK
10.21.1 Jiangsu GDK Company Information
10.21.2 Jiangsu GDK Introduction and Business Overview
10.21.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Jiangsu GDK Influenza Drugs and Vaccines Products Offered
10.21.5 Jiangsu GDK Recent Development
10.22 Sinovac
10.22.1 Sinovac Company Information
10.22.2 Sinovac Introduction and Business Overview
10.22.3 Sinovac Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Sinovac Influenza Drugs and Vaccines Products Offered
10.22.5 Sinovac Recent Development
10.23 Beike Bio
10.23.1 Beike Bio Company Information
10.23.2 Beike Bio Introduction and Business Overview
10.23.3 Beike Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Beike Bio Influenza Drugs and Vaccines Products Offered
10.23.5 Beike Bio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Drugs and Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Drugs and Vaccines Industrial Chain Analysis
11.4 Influenza Drugs and Vaccines Market Dynamics
11.4.1 Influenza Drugs and Vaccines Industry Trends
11.4.2 Influenza Drugs and Vaccines Market Drivers
11.4.3 Influenza Drugs and Vaccines Market Challenges
11.4.4 Influenza Drugs and Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Drugs and Vaccines Distributors
12.3 Influenza Drugs and Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Influenza Drugs
Table 2. Major Company of Influenza Vaccines
Table 3. Global Influenza Drugs and Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 5. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Influenza Drugs and Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Influenza Drugs and Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Influenza Drugs and Vaccines Price by Type (2018-2024) & (US$/Kg)
Table 9. Global Influenza Drugs and Vaccines Sales by Type (2024-2029) & (Tons)
Table 10. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Influenza Drugs and Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Influenza Drugs and Vaccines Sales Market Share in Value by Type (2024-2029)
Table 13. Global Influenza Drugs and Vaccines Price by Type (2024-2029) & (US$/Kg)
Table 14. North America Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 15. North America Influenza Drugs and Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Influenza Drugs and Vaccines Sales (Tons) by Type (2018-2024)
Table 17. Europe Influenza Drugs and Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Influenza Drugs and Vaccines Sales (Tons) by Type (2018-2024)
Table 19. Asia-Pacific Influenza Drugs and Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Influenza Drugs and Vaccines Sales (Tons) by Type (2018-2024)
Table 21. Latin America Influenza Drugs and Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Influenza Drugs and Vaccines Sales (Tons) by Type (2018-2024)
Table 23. Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Influenza Drugs and Vaccines Sales by Company (2018-2024) & (Tons)
Table 25. Global Influenza Drugs and Vaccines Sales Share by Company (2018-2024)
Table 26. Global Influenza Drugs and Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Influenza Drugs and Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Influenza Drugs and Vaccines Price by Company (2018-2024) & (US$/Kg)
Table 29. Global Influenza Drugs and Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Influenza Drugs and Vaccines Market
Table 33. Key Manufacturers Influenza Drugs and Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Influenza Drugs and Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Influenza Drugs and Vaccines Sales by Region (2018-2024) & (Tons)
Table 37. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Influenza Drugs and Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Influenza Drugs and Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 41. Global Influenza Drugs and Vaccines Sales by Region (2024-2029) & (Tons)
Table 42. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Influenza Drugs and Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Influenza Drugs and Vaccines Sales Market Share in Value by Region (2024-2029)
Table 45. Global Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2029)
Table 46. Global Influenza Drugs and Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Influenza Drugs and Vaccines Sales by Application (2018-2024) & (Tons)
Table 48. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Influenza Drugs and Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Influenza Drugs and Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Influenza Drugs and Vaccines Price by Application (2018-2024) & (US$/Kg)
Table 52. Global Influenza Drugs and Vaccines Sales by Application (2024-2029) & (Tons)
Table 53. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Influenza Drugs and Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Influenza Drugs and Vaccines Sales Market Share in Value by Application (2024-2029)
Table 56. Global Influenza Drugs and Vaccines Price by Application (2024-2029) & (US$/Kg)
Table 57. North America Influenza Drugs and Vaccines Sales by Application (2018-2024) (Tons)
Table 58. North America Influenza Drugs and Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Influenza Drugs and Vaccines Sales by Application (2018-2024) (Tons)
Table 60. Europe Influenza Drugs and Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Influenza Drugs and Vaccines Sales by Application (2018-2024) (Tons)
Table 62. Asia-Pacific Influenza Drugs and Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Influenza Drugs and Vaccines Sales by Application (2018-2024) (Tons)
Table 64. Latin America Influenza Drugs and Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2018-2024) (Tons)
Table 66. Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 68. North America Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Influenza Drugs and Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Influenza Drugs and Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 72. North America Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Influenza Drugs and Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Influenza Drugs and Vaccines Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 76. Europe Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Influenza Drugs and Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Influenza Drugs and Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 80. Europe Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Influenza Drugs and Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Influenza Drugs and Vaccines Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Influenza Drugs and Vaccines Sales by Region (2018-2024) & (Tons)
Table 84. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Influenza Drugs and Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Influenza Drugs and Vaccines Sales by Region (2024-2029) & (Tons)
Table 88. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Influenza Drugs and Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 92. Latin America Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Influenza Drugs and Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Influenza Drugs and Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 96. Latin America Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Influenza Drugs and Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Influenza Drugs and Vaccines Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 100. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 104. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Value by Country (2024-2029)
Table 107. CSL Company Information
Table 108. CSL Introduction and Business Overview
Table 109. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 110. CSL Influenza Drugs and Vaccines Product
Table 111. CSL Recent Development
Table 112. Bristol Myers Squibb Company Information
Table 113. Bristol Myers Squibb Introduction and Business Overview
Table 114. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 115. Bristol Myers Squibb Influenza Drugs and Vaccines Product
Table 116. Bristol Myers Squibb Recent Development
Table 117. AstraZeneca Company Information
Table 118. AstraZeneca Introduction and Business Overview
Table 119. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 120. AstraZeneca Influenza Drugs and Vaccines Product
Table 121. AstraZeneca Recent Development
Table 122. Eli Lilly Company Information
Table 123. Eli Lilly Introduction and Business Overview
Table 124. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 125. Eli Lilly Influenza Drugs and Vaccines Product
Table 126. Eli Lilly Recent Development
Table 127. Roche Company Information
Table 128. Roche Introduction and Business Overview
Table 129. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 130. Roche Influenza Drugs and Vaccines Product
Table 131. Roche Recent Development
Table 132. GlaxoSmithKline Company Information
Table 133. GlaxoSmithKline Introduction and Business Overview
Table 134. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 135. GlaxoSmithKline Influenza Drugs and Vaccines Product
Table 136. GlaxoSmithKline Recent Development
Table 137. Novartis Company Information
Table 138. Novartis Introduction and Business Overview
Table 139. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 140. Novartis Influenza Drugs and Vaccines Product
Table 141. Novartis Recent Development
Table 142. Pfizer Company Information
Table 143. Pfizer Introduction and Business Overview
Table 144. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 145. Pfizer Influenza Drugs and Vaccines Product
Table 146. Pfizer Recent Development
Table 147. Sanofi Company Information
Table 148. Sanofi Introduction and Business Overview
Table 149. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 150. Sanofi Influenza Drugs and Vaccines Product
Table 151. Sanofi Recent Development
Table 152. Bayer Company Information
Table 153. Bayer Introduction and Business Overview
Table 154. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 155. Bayer Influenza Drugs and Vaccines Product
Table 156. Bayer Recent Development
Table 157. Celgene Company Information
Table 158. Celgene Introduction and Business Overview
Table 159. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 160. Celgene Influenza Drugs and Vaccines Product
Table 161. Celgene Recent Development
Table 162. Seqirus Company Information
Table 163. Seqirus Introduction and Business Overview
Table 164. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 165. Seqirus Influenza Drugs and Vaccines Product
Table 166. Seqirus Recent Development
Table 167. Protein Sciences Corporation Company Information
Table 168. Protein Sciences Corporation Introduction and Business Overview
Table 169. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 170. Protein Sciences Corporation Influenza Drugs and Vaccines Product
Table 171. Protein Sciences Corporation Recent Development
Table 172. Serum Institute of India Company Information
Table 173. Serum Institute of India Introduction and Business Overview
Table 174. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 175. Serum Institute of India Influenza Drugs and Vaccines Product
Table 176. Serum Institute of India Recent Development
Table 177. Emergent Biosolutions Company Information
Table 178. Emergent Biosolutions Introduction and Business Overview
Table 179. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 180. Emergent Biosolutions Influenza Drugs and Vaccines Product
Table 181. Emergent Biosolutions Recent Development
Table 182. BioCryst Pharmaceuticals Company Information
Table 183. BioCryst Pharmaceuticals Introduction and Business Overview
Table 184. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 185. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product
Table 186. BioCryst Pharmaceuticals Recent Development
Table 187. Alvogen Company Information
Table 188. Alvogen Introduction and Business Overview
Table 189. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 190. Alvogen Influenza Drugs and Vaccines Product
Table 191. Alvogen Recent Development
Table 192. Viatris Company Information
Table 193. Viatris Introduction and Business Overview
Table 194. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 195. Viatris Influenza Drugs and Vaccines Product
Table 196. Viatris Recent Development
Table 197. Hulan Bio Company Information
Table 198. Hulan Bio Introduction and Business Overview
Table 199. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 200. Hulan Bio Influenza Drugs and Vaccines Product
Table 201. Hulan Bio Recent Development
Table 202. Changchun Institute of Biological Company Information
Table 203. Changchun Institute of Biological Introduction and Business Overview
Table 204. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 205. Changchun Institute of Biological Influenza Drugs and Vaccines Product
Table 206. Changchun Institute of Biological Recent Development
Table 207. Jiangsu GDK Company Information
Table 208. Jiangsu GDK Introduction and Business Overview
Table 209. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 210. Jiangsu GDK Influenza Drugs and Vaccines Product
Table 211. Jiangsu GDK Recent Development
Table 212. Sinovac Company Information
Table 213. Sinovac Introduction and Business Overview
Table 214. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 215. Sinovac Influenza Drugs and Vaccines Product
Table 216. Sinovac Recent Development
Table 217. Beike Bio Company Information
Table 218. Beike Bio Introduction and Business Overview
Table 219. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 220. Beike Bio Influenza Drugs and Vaccines Product
Table 221. Beike Bio Recent Development
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Influenza Drugs and Vaccines Market Trends
Table 225. Influenza Drugs and Vaccines Market Drivers
Table 226. Influenza Drugs and Vaccines Market Challenges
Table 227. Influenza Drugs and Vaccines Market Restraints
Table 228. Influenza Drugs and Vaccines Distributors List
Table 229. Influenza Drugs and Vaccines Downstream Customers
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs and Vaccines Product Picture
Figure 2. Global Influenza Drugs and Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Influenza Drugs and Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Influenza Drugs and Vaccines Sales Status and Outlook (2018-2029) & (Tons)
Figure 5. Product Picture of Influenza Drugs
Figure 6. Global Influenza Drugs Sales YoY Growth (2018-2029) & (Tons)
Figure 7. Product Picture of Influenza Vaccines
Figure 8. Global Influenza Vaccines Sales YoY Growth (2018-2029) & (Tons)
Figure 9. Global Influenza Drugs and Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2022 & 2029
Figure 11. North America Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Drugs and Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Drugs and Vaccines Revenue in 2022
Figure 23. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital Pharmacy
Figure 25. Global Hospital Pharmacy Sales YoY Growth (2018-2029) & (Tons)
Figure 26. Product Picture of Retail Pharmacy
Figure 27. Global Retail Pharmacy Sales YoY Growth (2018-2029) & (Tons)
Figure 28. Product Picture of Online Pharmacy
Figure 29. Global Online Pharmacy Sales YoY Growth (2018-2029) & (Tons)
Figure 30. Global Influenza Drugs and Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Influenza Drugs and Vaccines Sales Market Share by Application in 2022 & 2029
Figure 32. North America Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. North America Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Europe Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Europe Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Latin America Influenza Drugs and Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Influenza Drugs and Vaccines Manufacturing Cost Structure
Figure 43. Influenza Drugs and Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries